Testing effectiveness (Phase 2)UnknownNCT02660762What this trial is testingModified MRCUKALLⅫ/ECOGE2993 Regimen for ALLWho this might be right forLeukaemia,Lymphoblastic Sun Yat-sen University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04233346What this trial is testingThe Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I MutationWho this might be right forChronic Myeloid LeukemiaAcute Lymphoblastic Leukemia Otsuka Beijing Research Institute 93
Not applicableUnknownNCT02034656What this trial is testingPatterns of ABL Mutation in Asian With Imatinib Resistant Chronic Myeloid Leukemia and Ph Positive Acute Lymphocytc Leuekmia Patients (AMICA)Who this might be right forChronic Myeloid Leukemia or Ph Positive ALL Seoul St. Mary's Hospital 125
Testing effectiveness (Phase 2)Study completedNCT01279473What this trial is testingStudy to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)Who this might be right forChronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 42
Testing effectiveness (Phase 2)Study completedNCT01310010What this trial is testingStudy of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic LeukemiaWho this might be right forLeukemia, Lymphoblastic, Acute, Philadelphia-Positive Grupo Espanol de trasplantes hematopoyeticos y terapia celular 30
Testing effectiveness (Phase 2)Study completedNCT01256398What this trial is testingDasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07301424What this trial is testingSubcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALLWho this might be right forAcute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)BCR-ABL Positive Acute Lymphoblastic Leukemia University of Alberta 80
Early research (Phase 1)Looking for participantsNCT03595917What this trial is testingABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CMLWho this might be right forB-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL Marlise Luskin, MD 40
Early research (Phase 1)Active Not RecruitingNCT04872790What this trial is testingVenetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute LeukemiaWho this might be right forB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1Mixed Phenotype Acute Leukemia+2 more OHSU Knight Cancer Institute 20
Very early researchStudy completedNCT01184885What this trial is testingA Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyWho this might be right forLymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Early research (Phase 1)Ended earlyNCT03519984What this trial is testingEphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaWho this might be right forAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlasts 5 Percent or More of Bone Marrow Nucleated CellsMyelodysplastic/Myeloproliferative Neoplasm+8 more University of Southern California 3
Post-approval studies (Phase 4)Ended earlyNCT05071482What this trial is testingFlumatinib Versus Imatinib Combined With Chemotherapy for de Novo Ph+ ALLWho this might be right forAcute Leukemia Institute of Hematology & Blood Diseases Hospital, China 39
Testing effectiveness (Phase 2)Looking for participantsNCT06738368What this trial is testingEtoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic LeukemiaWho this might be right forB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeT Acute Lymphoblastic Leukemia University of Washington 30
Early research (Phase 1)Study completedNCT00807677What this trial is testingDose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more Millennium Pharmaceuticals, Inc. 31
Not applicableStudy completedNCT00003538What this trial is testingPrevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow TransplantationWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Looking for participantsNCT07441291What this trial is testingCD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCTWho this might be right forB ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive Peking University People's Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01207440What this trial is testingPonatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)Who this might be right forChronic Myeloid LeukemiaPh+ Acute Lymphoblastic Leukemia Ariad Pharmaceuticals 449
Testing effectiveness (Phase 2)Looking for participantsNCT04747912What this trial is testingStudy of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)Who this might be right forLymphoblastic LeukemiaAcute Lymphoblastic Leukemiaph+ Acute Lymphoblastic Leukemia University of Chicago 25
Testing effectiveness (Phase 2)Looking for participantsNCT06918431What this trial is testingAsparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWho this might be right forB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma City of Hope Medical Center 53
Testing effectiveness (Phase 2)Study completedNCT00618501What this trial is testingImatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Asan Medical Center 50